Asmacure Seeks Better Fix for Asthma, COPD
By Marie Powers
Wednesday, July 31, 2013
When it comes to treating pulmonary disease, Asmacure Ltée is seeking to build a better mousetrap. The Quebec City-based biotech was founded in 2002 by pulmonologist Yvon Cormier, the company's chief medical officer, who was exploring the role of nicotinic targets in inflammatory and pulmonary diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.